A Unique Regimen for Treatment of Helicobacter Pylori Infection
Status:
Recruiting
Trial end date:
2023-04-01
Target enrollment:
Participant gender:
Summary
The triple treatment including Proton pump inhibitor (PPI) -clarithromycin and amoxicillin or
metronidazole was proposed 30 years ago at the first Maastricht conference to treat
helicobacter pylori (H. pylori) infection and since that time, it has become the universal
and standard treatment for helicobacter pylori.
However, the efficacy of this triple regimen has been seriously challenged, and they are
gradually becoming ineffective